EGFR-targeted therapy resistance in breast and head & neck cancers
“By synthesizing current insights on both RTK and non-RTK mediated resistance against anti-EGFR therapies, this review aims to guide future research and improve therapeutic strategies for these cancers.”
2025-07-09
(Press-News.org)
“By synthesizing current insights on both RTK and non-RTK mediated resistance against anti-EGFR therapies, this review aims to guide future research and improve therapeutic strategies for these cancers.”
BUFFALO, NY – July 9, 2025 – A new review was published in Volume 16 of Oncotarget on June 25, 2025, titled “Challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer: Insights into RTK dependent and independent mechanisms.”
Researchers from the University of Cincinnati and Cincinnati Veterans Affairs Medical Center reviewed current research on why Epidermal Growth Factor Receptor (EGFR)-targeted therapies often fail in breast and head and neck cancers. The article by Shreya Shyamsunder, Zhixin Lu, Vinita Takiar, and Susan E. Waltz explores how cancer cells evade these treatments by activating alternative survival pathways. This review offers an in-depth look at the molecular barriers to EGFR inhibition and provides insights that could inform the development of more effective and durable treatments.
EGFR is a critical protein that regulates cell growth and survival, and it is frequently overexpressed in breast and head and neck cancers. Although therapies targeting EGFR showed early promise, resistance has become a significant challenge. In breast cancer, resistance mechanisms include the movement of EGFR from the cell surface into the nucleus, where it promotes DNA repair, as well as ligand-dependent activation that helps tumor growth despite therapy. In head and neck cancers, resistance often arises from inflammatory signaling through the TLR4-MyD88 pathway and the loss of tumor suppressor genes like PTEN, which allow cancer cells to bypass EGFR inhibition. The review also describes how tumor cells in both cancers commonly activate other receptor tyrosine kinases (RTKs), such as MET, AXL, and RON, to continue growing even when EGFR is blocked.
By analyzing these resistance mechanisms, the authors highlight combination therapies from current research that target EGFR and other key molecular pathways. Strategies such as dual inhibition of EGFR and MET or blocking inflammation-driven survival signals may enhance treatment outcomes. Several clinical trials are evaluating these approaches in patients. For example, in breast cancer, combinations of EGFR inhibitors with chemotherapy and immune checkpoint inhibitors are being tested to improve responses, particularly in triple-negative breast cancer. In head and neck cancers, trials are investigating EGFR-blocking antibodies like cetuximab combined with immunotherapies such as pembrolizumab and nivolumab. These efforts aim to overcome resistance and provide more effective treatment options for patients with EGFR-driven tumors. The review also emphasizes the necessity of identifying biomarkers to predict which patients are most likely to benefit from EGFR-based therapies.
“A recent phase 1 study has shown that patients with recurrent or metastatic head and neck cancer who received BCA101, a bifunctional dual targeting drug that targets EGFR and TGF-β in combination with pembrolizumab, were able to achieve an overall response rate of 65%.”
This work brings together current knowledge about EGFR resistance and illustrates the difficulties involved in treating breast and head and neck cancers. By mapping the many ways tumors overcome EGFR inhibition, the review highlights opportunities for more tailored and effective treatments in the future.
Continue reading: DOI: https://doi.org/10.18632/oncotarget.28747
Correspondence to: Susan E. Waltz – susan.waltz@uc.edu; Vinita Takiar – takiarva@ucmail.uc.edu
Keywords: EGFR; RTKs; breast cancer; head and neck cancer; resistance mechanisms
Click here to sign up for free Altmetric alerts about this article.
About Oncotarget:
Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
X
Facebook
YouTube
Instagram
LinkedIn
Pinterest
Spotify, and available wherever you listen to podcasts
Click here to subscribe to Oncotarget publication updates.
For media inquiries, please contact media@impactjournals.com.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-07-09
(Toronto, July 9, 2025) JMIR Publications invites submissions to a new theme issue titled “Ambient AI Scribes and AI-Driven Documentation Technologies” in its open access journal JMIR Medical Informatics. The premier, peer-reviewed journal is indexed in MEDLINE, PubMed, PubMed Central, DOAJ, Scopus, and the Science Citation Index Expanded (SCIE).
Recent developments in generative artificial intelligence (AI) offer a promising pathway for reducing long-standing administrative burdens for physicians and clinicians. Specifically, there is a rapidly evolving field of ambient AI ...
2025-07-09
Background and Aims
Acute hepatitis E (AHE) in the elderly can lead to severe complications including liver failure and mortality, yet the epidemiological landscape remains poorly characterized. This study aimed to assess the burden, trends, and health inequalities of AHE among the elderly over the past three decades, and to further predict its changes by 2030.
Methods
Data on AHE in the elderly were obtained from the Global Burden of Disease 2021. The burden of AHE was analyzed by trends, decomposition, cross-country inequalities, and predictive analysis.
Results
In 2021, the global incidence and Disability-Adjusted Life Years (DALYs) for AHE among the elderly ...
2025-07-09
A research team led by Dr. Kee Young Koo from the Hydrogen Research Department at the Korea Institute of Energy Research (President: Yi Chang-Keun, hereafter referred to as KIER) has developed a novel and more cost-effective method for synthesizing ammonia decomposition catalysts. This new approach enables more efficient hydrogen production from ammonia and is expected to make a significant contribution to the realization of a hydrogen economy.
Composed of three hydrogen atoms and one nitrogen atom, ammonia has a high hydrogen content, ...
2025-07-09
Mesophotic coral ecosystems (MCEs) are important coral ecosystems found between 30 and 150 meters deep in oceans worldwide including the Gulf of America. They support diverse marine life and important fisheries but remain poorly understood. Unlike shallow reefs, MCEs depend on nutrients from the deep ocean from upwelling or river plumes, like those from the Mississippi and Apalachicola rivers. These nutrient flows support growth of marine phytoplankton (i.e. tiny floating algae), which is an important source of organic matter (food) that sustains the corals and other marine species.
However, scientists have ...
2025-07-09
PULLMAN, Wash. -- Groundwater is declining across Eastern Washington’s complex, interconnected aquifer system, as people draw on it for irrigation, drinking and other uses at a pace that threatens its sustainability, according to a new study by a Washington State University researcher.
In certain “hot spots” – such as the Odessa region and the Yakima Basin – the rates of decline are particularly significant, with groundwater levels dropping two to three feet a year or more.
The data is built ...
2025-07-09
Creatine is popularly known as a muscle-building supplement, but its influence on human muscle function can be a matter of life or death.
“Creatine is very crucial for energy-consuming cells in skeletal muscle throughout the body, but also in the brain and in the heart,” said Chin-Yi Chen, a research scientist at Virginia Tech’s Fralin Biomedical Research Institute at VTC.
Chen is part of a research team working to develop a technique that uses focused ultrasound to deliver creatine directly to the brain. The work, being conducted ...
2025-07-09
CO2 concentrations vary widely depending on the source, ranging, for example, from about 0.04% in the atmosphere to about 10% in flue gases. Moreover, these gas streams contain a significant amount of O2 (about 10%), a potent oxidizing agent. To achieve carbon neutrality, it is necessary to develop a robust process that can convert CO2 over a wide concentration range, even in the presence of O2. However, current technology does not offer a single unified approach that can efficiently handle CO2 conversion from trace to high concentrations. To meet this challenge, researchers at Hokkaido University and collaborators ...
2025-07-09
WASHINGTON—A new Scientific Statement released today by the Endocrine Society highlights potential research directions related to the pathogenesis of type 1 diabetes (T1D) that should help with the development of new and improved treatment options.
Type 1 diabetes is a chronic disease where the body's immune system attacks and destroys insulin-producing cells in the pancreatic islet. Type 1 diabetes requires lifelong insulin administration and may result in complications such as eye, kidney, nerve, and heart disease. ...
2025-07-09
PITTSBURGH, July 9, 2025 — During the menopause transition, only 1 in 5 women have optimal scores using the American Heart Association’s health-assessment tool, known as Life’s Essential 8 (LE8). Among the tool’s eight components, four of them — blood glucose, blood pressure, sleep quality and nicotine use — are key in driving future cardiovascular risks, with sleep being particularly crucial for long-term cardiovascular health.
The findings – published today in Menopause – were made by researchers at the University of Pittsburgh, Albert Einstein College of Medicine and Baylor University.
“Previously ...
2025-07-09
It’s been recognized for some time that Alzheimer’s disease affects brain regions differently and that tau — a protein known to misbehave — plays an important role in the disease. Normally, tau helps stabilize neurons, but in Alzheimer’s disease, it begins to misfold and tangle inside neurons. It spreads across the brain forming toxic clumps that impair neuronal function and ultimately lead to cell death.
Brain areas like the entorhinal cortex and hippocampus succumb early to tau tangles, while other areas, like the primary sensory cortices, remain resilient to the disease. In the quest to better understand this selective ...
LAST 30 PRESS RELEASES:
[Press-News.org] EGFR-targeted therapy resistance in breast and head & neck cancers
“By synthesizing current insights on both RTK and non-RTK mediated resistance against anti-EGFR therapies, this review aims to guide future research and improve therapeutic strategies for these cancers.”
